Aurinia Pharmaceuticals Files SEC Report, Shares Trade on Nasdaq
Company Announcements

Aurinia Pharmaceuticals Files SEC Report, Shares Trade on Nasdaq

Story Highlights

Aurinia Pharmaceuticals (AUPH) has released an update.

Aurinia Pharmaceuticals Inc., a Canadian company, has filed a current report on Form 8-K with the U.S. Securities and Exchange Commission to comply with Sections 13 or 15(d) of the Securities Exchange Act of 1934, as of August 1, 2024. The report reveals the company’s common shares are registered and traded on The Nasdaq Stock Market under the symbol AUPH.

For further insights into AUPH stock, check out TipRanks’ Stock Analysis page.

Related Articles
Radhika Saraogi3 Best Stocks to Buy Now, 11/11/2024, According to Top Analysts 
TipRanks Auto-Generated NewsdeskAurinia Pharmaceuticals Reports Strong Growth and Strategic Restructuring
TheFlyUnusually active option classes on open November 7th
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App